نتایج جستجو برای: interferon therapy

تعداد نتایج: 712677  

Journal: :iranian journal of neurology 0
seyed massood nabavi ms research unit, neurology department, shahed university, tehran, iran. ali hamzehloo ms research unit, neurology department, shahed university, tehran, iran jalaledin shams hematology-oncology unit, internal medicine department, shahed university, tehran, iran damineh morsali medical school at houston, texas

background: interferon beta-la and -1b have been increasingly used for the treatment of multiple sclerosis (ms). the most frequent systemic adverse effects are flu-like symptoms. laboratory abnormalities include asymptomatic leukopenia and elevated hepatic transaminases. myelodysplastic syndrome (mds) refers to a spectrum of hematological disorders which can occur in different situations. sever...

Journal: :hepatitis monthly 0
kamuran turker department of infectious diseases, ministry of health bagcilar state hospital, istanbul, turkey; department of infectious diseases, ministry of health bagcilar state hospital, istanbul, turkey. tel: +90-2124404000, fax: +90-2124404242 betul tas department of dermatology, ministry of health bagcilar state hospital, istanbul, turkey murat ozkaya department of physical medicine and rehabilitation, ministry of health bagcilar state hospital, istanbul, turkey ebru tas department of gastroenterology, dumlupinari university faculty of medicine, evliya celebi research and training hospital, kutahya, turkey aysel caglar department of pathology, ministry of health bagcilar state hospital, istanbul, turkey umit seza tetikkurt department of pathology, ministry of health bagcilar state hospital, istanbul, turkey

introduction various types of dermatological manifestations have been reported due to hepatitis c virus (hcv) infection and anti­hcv therapy. some of them have been described during ifn-based therapies. peg-ifn-α-2a/rbv combination is used as the international standard of treatment for hcv infection for a long time. the combination therapy yields an adverse-event profile similar to standard int...

A Shokoohi SM Alavian

α-Interferon is an antiviral agent used in treatment of chronic hepatitis B. Triggering of the underlying autoimmune disease or exacerbation of pre-existing auto immune disease is documented with α-interferon, but there are few reports about occurrence of autoimmune disorders such as systemic lupus erythematosus, Vitiligo, hypo and hyperthyroidism after administration of α-interferon in the lit...

Journal: :hepatitis monthly 0
yue-li xiong department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china fen liu department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china fen liu department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china dazhi zhang department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china hong ren department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china peng hu department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china; department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china. tel: +86-2363693289, fax: +86-2363703790

background after treatment cessation, a high prevalence of relapse was reported in chronic hepatitis b (chb) patients in china, especially in nucleot(s)ide analogues (nucs)-experienced patients. re-treatment for these patients remains unsolved. objectives this study aims to evaluate the efficacy of pegylated interferon in hbeag positive patients with exposure to antiviral therapy. patients and ...

Journal: :hepatitis monthly 0
ligita jancoriene department of infectious, chest diseases, dermatovenerology and alergology, faculty of medicine, vilnius university, vilnius, lithuania; department of infectious, chest diseases, dermatovenerology and alergology, faculty of medicine, vilnius university, vilnius, lithuania. tel: +37-68785870, fax: +37-52752790 dovile norvydaite department of otolaryngology and eye diseases, faculty of medicine, vilnius university, vilnius, lithuania saulius galgauskas department of otolaryngology and eye diseases, faculty of medicine, vilnius university, vilnius, lithuania evelina balciunaite department of xx, faculty of medicine, vilnius university, vilnius, lithuania

introduction patients with hepatitis c are commonly treated with combination of pegylated interferon alfa-2a and ribavirin. less than 1% of patients receiving this treatment experience very uncommon ophthalmological side effects such as optic neuropathy and vision disorder, which are usually subclinical, mild and reversible, not requiring the withdrawal of the treatment. retinopathy is the most...

Journal: :hepatitis monthly 0
reza karbasi-afshar cardiovascular diseases department, baqiyatallah university of medical sciences, tehran, ir iran amin saburi chemical injuries research center, baqiyatallah university of medical sciences, tehran, ir iran; baqiyatallah research center of gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran; chemical injuries research center and baqiyatallah research center of gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, mollasadra st, vanaksq, tehran, ir iran. tel/fax: +98-2188600067

Journal: :hepatitis monthly 0
imran tipu institute of biochemistry and biotechnology, university of the punjab, lahore, pakistan; manchester institute of biotechnology, university of manchester, manchester, uk; institute of biochemistry and biotechnology, university of the punjab, lahore, pakistan. tel: +92-3214029804 fiona marriage manchester institute of biotechnology, university of manchester, manchester, uk; centre for integrated genomic medical research, university of manchester, manchester, uk zia-ur-rahman farooqi manchester institute of biotechnology, university of manchester, manchester, uk; national university of science and technology, islamabad, pakistan hazel platt centre for integrated genomic medical research, university of manchester, manchester, uk muhammad amin athar institute of biochemistry and biotechnology, university of the punjab, lahore, pakistan philip john day manchester institute of biotechnology, university of manchester, manchester, uk; centre for integrated genomic medical research, university of manchester, manchester, uk

background polymorphisms in the interferon λ (inf λ) genes on chromosome 19 have been associated with clearance of hepatitis c virus (hcv) induced by interferon and ribavirin therapy however there is no such data available for pakistani patients with hcv infection. objectives in this study, the effects of single nucleotide polymorphisms (snps) have been investigated in response to treatment wit...

Journal: :iranian journal of neurology 0
payam khomand department of neurology, school of medicine, tohid hospital, kurdistan university of medical sciences, sanandaj, iran ghobad moradi social determinants of health research center, department of epidemiology and biostatistics, school of medicine, kurdistan university of medical sciences, sanandaj, iran setareh abtahi department of neurology, school of medicine, tohid hospital, kurdistan university of medical sciences, sanandaj, iran behrooz ahsan department of neurology, school of medicine, tohid hospital, kurdistan university of medical sciences, sanandaj, iran

abstract introduction:  this study was performed to compare the effects of low-dose interferon beta-1(cinnovex,30 mcg) and high-dose interferon beta-1(rebif,44 mcg) on the reduction of the number and size of plaques in magnetic resonance imaging (mri) in patients with multiple sclerosis (ms). methods and materials: this historical cohort study, which was performed in 2014 in sanandaj (western p...

ابراهیمی دریانی, ناصر , ثمر, گیتی , یلدا, علیرضا ,

Alpha-interferon therapy has been approved for treatment of chronic hepatitis C and B. Candidates for treatment are patients with well-compensated liver disease and histologic evidences of chronic hepatitis who have demonstrated abnormal aminotransferase levels for more than 6 months. From 30 patients with chronic hepatitis with diseases prolonged more than 6 months, we selected only 16 patient...

Journal: :journal of research in medical sciences 0
hamid kalantari associate professor, department of gastroenterology, school of medicine, isfahan university of medical sciences, isfahan, iran. neda rad resident of internal medicine, school of medicine, isfahan university of medical sciences, isfahan, iran.

background: the aim of this study was to evaluate the effectiveness of monotherapy with interferon alpha-2b and combination therapy with interferon alpha-2b plus ribavirin on chronic hepatitis c infection in thalassaemic patients. methods: in parallel group randomized, double blind, controlled trial, 32 thalassaemic patients with chronic hepatitis c infection completed the study. in a random fa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید